Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN116283922A reveals a Bronsted acid-catalyzed method for EGFR inhibitor intermediates, offering higher yields and metal-free processing for reliable supply chains.
Novel Mn-catalyzed asymmetric oxidation offers high enantioselectivity and mild conditions for scalable pharmaceutical intermediate production.
Novel condensation method for Argatroban intermediate ensures high purity and scalable production. Reduces impurities significantly for reliable pharmaceutical supply chains.
Patent CN111393333B details a green aqueous silver-catalyzed dearomatization method. This breakthrough offers high regioselectivity and scalable production for pharmaceutical intermediates.
Patent CN111138392B reveals a mild 90-120°C route to 2,5-Furandicarboxylic Acid from furfural using O2 and CO2, offering significant cost reduction in polymer additive manufacturing.
Patent CN107540616B details a novel 4-step route to chiral pyrazolamines with 94% ee, offering significant cost reduction and supply chain reliability for agrochemical and pharmaceutical manufacturing.
Patent CN103012498A reveals high-efficiency Ir-catalysts for ketone reduction, offering scalable routes for chiral pharmaceutical intermediates.
Novel catalytic method for imidazolone compounds ensures high yield and purity. Ideal for pharmaceutical intermediates supply chain optimization and cost reduction.
Patent CN106045916B reveals a high-yield synthetic method for imidazolone compounds using a unique Ru-Ce catalyst system, offering significant supply chain advantages.
Novel nitro reduction method inhibits azo impurities. Ensures high purity and supply chain reliability for pharmaceutical intermediates.
Patent CN111995635A details a green method for organosilicon synthesis using chitosan-supported copper nanoparticles in water, offering significant cost and supply chain advantages.
Patent CN115043775B reveals a novel chiral pyridoxal catalyst enabling biomimetic aldol reactions for beta-amino alcohol synthesis with high enantioselectivity and scalable manufacturing potential.
Patent CN110845305B details a high-yield route to L-menthol using organoaluminum catalysts and chiral resolution, offering cost-effective supply chain solutions.
Patent CN108176392B reveals a composite catalyst for MDA production, eliminating caustic neutralization. Offers significant cost reduction and purity improvements for polyurethane precursors.
High-yield green synthesis of PMVE via ionic liquid catalysis. Enhances supply chain reliability and reduces manufacturing costs for fluoropolymer production.
Novel micron-order sodium carbonate method for Linagliptin. Reduces catalyst cost, improves purity >99.7%, suitable for commercial scale-up.
Patent CN113801859A details high-efficiency carbonyl reductase mutants for chiral alcohol synthesis, offering superior stereoselectivity and cost reduction in pharmaceutical manufacturing.
Advanced patent-based synthesis of Vildagliptin impurities ensures high purity. Optimized process offers significant supply chain reliability and cost reduction benefits.
Novel two-step methylation process enhances yield and safety for hydroquinone monomethyl ether production, offering significant supply chain and cost advantages.
Novel Amberlyst 15 catalyzed route for Bisolvon reduces toxicity and steps. Offers cost reduction in pharmaceutical manufacturing and high-purity API intermediate supply.